217 related articles for article (PubMed ID: 35446354)
1. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry.
Ding WY; Proietti M; Boriani G; Fauchier L; Blomström-Lundqvist C; Marin F; Potpara TS; Lip GYH;
Europace; 2022 May; 24(5):721-728. PubMed ID: 35446354
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility and prognostic implications of the 4S-AF scheme: Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.
Chao TF; Tse HF; Teo WS; Park HW; Shimizu W; Chen SA; Lip GYH;
Eur J Clin Invest; 2022 Oct; 52(10):e13825. PubMed ID: 35700114
[TBL] [Abstract][Full Text] [Related]
3. Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry.
Rivera-Caravaca JM; Piot O; Roldán-Rabadán I; Denis A; Anguita M; Mansourati J; Pérez-Cabeza A; Marijon E; García-Seara J; Leclercq C; García-Bolao I; Lellouche N; Potpara T; Boriani G; Fauchier L; Lip GYH; Marín F
Europace; 2022 Feb; 24(2):202-210. PubMed ID: 34374759
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction.
Luo J; Li Z; Qin X; Zhang X; Liu X; Zhang W; Xu W; Zhang Y; Fang Y; Liu B; Wei Y;
Eur J Intern Med; 2023 Jul; 113():38-44. PubMed ID: 37037721
[TBL] [Abstract][Full Text] [Related]
5. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
6. Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry.
Ding WY; Blomström-Lundqvist C; Fauchier L; Marin F; Potpara TS; Boriani G; Lip GYH
Europace; 2023 Feb; 25(2):277-282. PubMed ID: 36427202
[TBL] [Abstract][Full Text] [Related]
7. Adherence to the "Atrial fibrillation Better Care" (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry.
Vitolo M; Proietti M; Malavasi VL; Bonini N; Romiti GF; Imberti JF; Fauchier L; Marin F; Nabauer M; Potpara TS; Dan GA; Kalarus Z; Maggioni AP; Lane DA; Lip GYH; Boriani G;
Eur J Intern Med; 2022 Nov; 105():54-62. PubMed ID: 36028394
[TBL] [Abstract][Full Text] [Related]
8. Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry.
Ding WY; Proietti M; Romiti GF; Vitolo M; Fawzy AM; Boriani G; Marin F; Blomström-Lundqvist C; Potpara TS; Fauchier L; H Lip GY;
Eur J Intern Med; 2023 Jan; 107():60-65. PubMed ID: 36372692
[TBL] [Abstract][Full Text] [Related]
9. Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort.
Malavasi VL; Vitolo M; Colella J; Montagnolo F; Mantovani M; Proietti M; Potpara TS; Lip GYH; Boriani G
Intern Emerg Med; 2022 Jun; 17(4):1001-1012. PubMed ID: 34855117
[TBL] [Abstract][Full Text] [Related]
10. Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry.
Ding WY; Potpara TS; Blomström-Lundqvist C; Boriani G; Marin F; Fauchier L; Lip GYH;
Eur J Clin Invest; 2022 Jun; 52(6):e13745. PubMed ID: 35000206
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
12. Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry.
Proietti M; Lip GYH; Laroche C; Fauchier L; Marin F; Nabauer M; Potpara T; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Boriani G;
Europace; 2021 Feb; 23(2):174-183. PubMed ID: 33006613
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study.
Artola Arita V; Van De Lande ME; Khalilian Ekrami N; Nguyen BO; Van Melle JM; Geelhoed B; De With RR; Weberndörfer V; Erküner Ö; Hillege H; Linz D; Ten Cate H; Spronk HMH; Koldenhof T; Tieleman RG; Schotten U; Crijns HJGM; Van Gelder IC; Rienstra M
Europace; 2023 Apr; 25(4):1323-1331. PubMed ID: 36857318
[TBL] [Abstract][Full Text] [Related]
14. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry.
Boriani G; Proietti M; Laroche C; Fauchier L; Marin F; Nabauer M; Potpara T; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GYH;
Europace; 2019 Jul; 21(7):1013-1022. PubMed ID: 30904925
[TBL] [Abstract][Full Text] [Related]
15. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry.
Romiti GF; Proietti M; Vitolo M; Bonini N; Fawzy AM; Ding WY; Fauchier L; Marin F; Nabauer M; Dan GA; Potpara TS; Boriani G; Lip GYH;
BMC Med; 2022 Sep; 20(1):326. PubMed ID: 36056426
[TBL] [Abstract][Full Text] [Related]
16. Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
Proietti M; Laroche C; Nyvad O; Haberka M; Vassilikos VP; Maggioni AP; Boriani G; Lip GYH;
Int J Cardiol; 2017 Dec; 248():166-172. PubMed ID: 28859841
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC-EHRA EORP AF Long-Term General Registry.
Ding WY; Boriani G; Marin F; Blomström-Lundqvist C; Potpara TS; Fauchier L; Lip GYH;
Eur Heart J Cardiovasc Pharmacother; 2022 Jun; 8(4):372-382. PubMed ID: 34665249
[TBL] [Abstract][Full Text] [Related]
18. 4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients.
Guo Y; Imberti JF; Kotalczyk A; Wang Y; Lip GYH;
Eur J Clin Invest; 2022 Jun; 52(6):e13751. PubMed ID: 35080269
[TBL] [Abstract][Full Text] [Related]
19. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
[TBL] [Abstract][Full Text] [Related]
20. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
